14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $5.34 $19.02 Monday, 6th May 2024 CNTA stock ended at $9.25. This is 2.32% less than the trading day before Friday, 3rd May 2024. During the day the stock fluctuated 2.81% from a day low at $9.24 to a day high of $9.50.
90 days $17.30 $19.02
52 weeks $16.32 $20.85

Historical Centessa Pharmaceuticals Limited prices

Date Open High Low Close Volume
Feb 23, 2024 $10.90 $11.11 $10.46 $11.01 327 835
Feb 22, 2024 $10.50 $11.32 $10.41 $10.75 180 765
Feb 21, 2024 $10.18 $10.50 $10.00 $10.40 979 021
Feb 20, 2024 $11.60 $11.95 $10.55 $10.66 189 340
Feb 16, 2024 $10.68 $11.86 $10.68 $11.75 669 979
Feb 15, 2024 $10.18 $10.84 $10.18 $10.83 634 692
Feb 14, 2024 $9.65 $10.20 $9.53 $10.18 1 194 975
Feb 13, 2024 $9.39 $9.59 $9.00 $9.50 658 314
Feb 12, 2024 $9.41 $9.95 $9.26 $9.60 779 256
Feb 09, 2024 $9.00 $9.40 $8.35 $9.26 3 024 364
Feb 08, 2024 $7.63 $7.88 $7.38 $7.46 118 339
Feb 07, 2024 $7.93 $8.22 $7.50 $7.57 158 554
Feb 06, 2024 $8.08 $8.35 $8.00 $8.12 208 461
Feb 05, 2024 $7.72 $8.32 $7.72 $8.15 2 235 348
Feb 02, 2024 $7.89 $8.12 $7.71 $7.87 211 950
Feb 01, 2024 $8.21 $8.48 $7.62 $8.01 1 518 113
Jan 31, 2024 $8.32 $8.65 $8.15 $8.19 432 640
Jan 30, 2024 $8.69 $8.84 $8.15 $8.27 331 154
Jan 29, 2024 $8.19 $8.78 $8.04 $8.78 380 151
Jan 26, 2024 $7.61 $8.22 $7.61 $8.11 392 359
Jan 25, 2024 $8.06 $8.10 $7.81 $7.83 97 635
Jan 24, 2024 $8.14 $8.33 $7.75 $8.00 1 435 487
Jan 23, 2024 $8.17 $8.90 $7.99 $8.04 269 308
Jan 22, 2024 $8.14 $8.49 $7.87 $8.14 271 588
Jan 19, 2024 $7.58 $8.21 $7.58 $8.10 55 297
Click to get the best stock tips daily for free!

About Centessa Pharmaceuticals Limited

Centessa Pharmaceuticals Limited Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; and SerpinPC, an activated protein C inhibitor, which is in Phase IIa clinical development for the treatm... CNTA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT